Evidence map›Paper›PMID 33362798›Full record

ArticleFrontiers in immunology2020

Innovation in Nucleotide-Binding Oligomerization-Like Receptor and Toll-Like Receptor Sensing Drives the Major Histocompatibility Complex-II Free Atlantic Cod Immune System.

Xingkun Jin, Bernat Morro, Ole K Tørresen, Visila Moiche, Monica H Solbakken, Kjetill S Jakobsen, Sissel Jentoft, Simon MacKenzie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. TLR25 is endosomally located and responds toFrontiers in immunology · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Xingkun JinCentre for Ecological and Evolutionary Synthesis (CEES), Department of Biosciences, University of Oslo, Oslo, Norway.
Bernat MorroInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Ole K TørresenCentre for Ecological and Evolutionary Synthesis (CEES), Department of Biosciences, University of Oslo, Oslo, Norway.
Visila MoicheInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
Monica H SolbakkenCentre for Ecological and Evolutionary Synthesis (CEES), Department of Biosciences, University of Oslo, Oslo, Norway.
Kjetill S JakobsenCentre for Ecological and Evolutionary Synthesis (CEES), Department of Biosciences, University of Oslo, Oslo, Norway.
Sissel JentoftCentre for Ecological and Evolutionary Synthesis (CEES), Department of Biosciences, University of Oslo, Oslo, Norway.
Simon MacKenzieInstitute of Aquaculture, University of Stirling, Stirling, United Kingdom.
University of Oslo · NOUniversity of Stirling · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absence of MHC class II antigen presentation and multiple pathogen recognition receptors in the Atlantic cod has not impaired its immune response however how underlying mechanisms have adapted remains largely unknown. In this study,

Indexed as

AnimalsCells, CulturedGadus morhuaHumansImmune SystemInterferon Regulatory FactorsMacrophagesMajor Histocompatibility ComplexNF-kappa BNLR ProteinsNucleotidesSignal TransductionToll-Like ReceptorsInterferon Regulatory FactorsNF-kappa BNLR ProteinsNucleotidesToll-Like Receptorscodimmune responsemacrophagenucleotide-binding oligomerization-like receptor (NLR)Toll-like receptor (TLR)

Identifiers

PMID33362798
PMCPMC7759675
OpenAlexW3111222891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.